MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by YANG, H.-Y. T.
Right arrow Articles by NEFF, N. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by YANG, H.-Y. T.
Right arrow Articles by NEFF, N. H.

Molecular Pharmacology, Vol 12, 69-72, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

N-Acetyltransferase of Brain: Some Properties of the Enzyme and the Identification of beta-Carboline Inhibitor Compounds

H.-Y. T. YANG 1 and N. H. NEFF 1

1 Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D. C. 20032

Several beta-carboline derivatives, such as harmane, harmol, 6-methoxyharman, and melatonin, inhibited the N-acetylation of tryptamine by brain N-acetyltransferase. The enzyme of brain was active toward several indole- and phenylethylamine substrates. In contrast to the enzyme of brain, the enzyme of pineal was not inhibited by harmaline and harman, and 3,4-dimethoxyphenylethylamine was a relatively poor substrate. beta-carboline inhibitors may be useful aids for studying the various N-acetyltransferases and for evaluating the physiological role of the brain enzyme.

Note:
ACKNOWLEDGMENT We thank Jeffrey Rubenstein for his expert technical assistance.

Submitted on March 7, 1975







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics